Suhkneung Pyo

Dr. Suhkneung Pyo

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
JKJi-Yun Kim
Ji-Yun Kim
JPJames C. Paton
James C. Paton
DBDavid E. Briles
David E. Briles
DRDong-Kwon Rhee
Dong-Kwon Rhee
SPSuhkneung Pyo
Suhkneung Pyo
Streptococcus pneumoniae induces pyroptosis through the regulation of autophagy in murine microglia

18 June 2015 in Food & Function
Verified
Journal Article
Closed access
PDF file
YJYeon Jeong Jang
Yeon Jeong Jang
HKHyun Jung Koo
Hyun Jung Koo
ESEun-Hwa Sohn
Eun-Hwa Sohn
SKSe Chan Kang
Se Chan Kang
DRDong-Kwon Rhee
Dong-Kwon Rhee
SPSuhkneung Pyo
Suhkneung Pyo
Obesity is characterized by hypertrophy and/or by the differentiation or adipogenesis of pre-existing adipocytes. In this study, we investigated the inhibitory effects of theobromine, a type of alkaloid in cocoa, on adipocyte differentiation of 3T3-L1 preadipocytes and its mechanisms of action. Theobromine inhibited the accumulation of lipid droplets, the expression of PPARγ and C/EBPα, and the mRNA expression of aP2 and leptin. The inhibition of adipogenic differentiation by theobromine occurred primarily in the early stages of differentiation. In addition, theobromine arrested the cell cycle at the G0/G1 phase and regulated the expressions of CDK2, p27, and p21. Theobromine treatment increased AMPK phosphorylation and knockdown of AMPKα1/α2 prevented the ability of theobromine to inhibit PPARγ expression in the differentiating 3T3-L1 cells. Theobromine reduced the phosphorylation of ERK and JNK. Moreover, the secretion and the mRNA level of TNF-α and IL-6 were inhibited by theobromine treatment. These data suggest that theobromine inhibits adipocyte differentiation during the early stages of adipogenesis by regulating the expression of PPARγ and C/EBPα through the AMPK and ERK/JNK signaling pathways in 3T3-L1 preadipocytes.

23 April 2013 in Journal of Applied Microbiology
Verified
Journal Article
Open access
PDF file
JKJ.-Y. Kim
J.-Y. Kim
BPB.-K. Park
B.-K. Park
HPH.-J. Park
H.-J. Park
YPY.-H. Park
Y.-H. Park
BKB.-O. Kim
B.-O. Kim
SPSuhkneung Pyo
Suhkneung Pyo
Aims Atopic dermatitis (AD) is an inflammatory skin disease. Probiotics have been reported to modulate immune responses and thus are now being suggested as potential treatments for allergies. In this study, we investigated the inhibitory effects of Lactobacillus sakei probio 65 isolated from Kimchi on artificially inducing AD in NC/Nga mice. Methods and Results Oral administration of viable or heat-inactivated Lact. sakei probio 65 improved the condition of skin and reduced scratching frequency. Serum levels of IgE and cutaneous T-cell-attracting chemokine (CTACK) were significantly decreased by this therapy. Dead Lact. sakei probio 65 also decreased IL-4 and IL-6 serum concentrations. Moreover, both live and dead Lact. sakei probio 65 inhibited the expression of Thymus and activation-regulated chemokine and CTACK in AD-like skin lesions. The increased levels of Foxp3 expression in the lesional skin and ears were also suppressed by Lact. sakei probio 65. In addition, Lact. sakei probio 65 inhibited β-hexosaminidase release and the secretion of IL-4, TNF-α and IL-6 from RBL-2H3 cells. Conclusions Oral treatment with both viable and heat-inactivated Lact. sakei probio 65 inhibits skin inflammation and AD-like skin lesions, as well as mast cell activation. Significance and Impact of the Study Lactobacillus sakei probio 65 has an inhibitory effect on atopic dermatitis-like skin lesions and may represent an effective new anti-inflammatory agent.

1 December 2005 in Journal of Toxicology and Environmental Health, Part A
Verified
Journal Article
Closed access
SISang-Whan In
Sang-Whan In
ESEun-Wha Son
Eun-Wha Son
DRDong-Kwon Rhee
Dong-Kwon Rhee
SPSuhkneung Pyo
Suhkneung Pyo
The abuse of methamphetamine (MA) is an increasingly growing problem globally and produces serious side effects. In the present study, the immunomodulating effects of MA were examined on the immune system after MA (5 mg/kg body weight) was administered daily orally for 14 d. The immune system was evaluated by the antibody response to sheep red blood cells (SRBC; plaque assay and serum immunoglobulin [Ig] G), natural killer (NK) activity, lymphocyte subpopulations in the spleen and thymus, and concanavalin A (Con A)- and lipopolysaccharide (LPS)-stimulated lymphocyte proliferation using splenocytes. Body weight, spleen weight, and thymus weight generally decreased in MA-treated mice. MA treatment induced an increase in the percentage of CD4+ cells with simultaneous decrease in the percentages of CD8+ and double-positive CD4+CD8+ in thymus. MA inhibited the IgM plaque-forming cell number, and lowered the level of IgG, the proliferation of mitogen-stimulated B and T cells, and the growth of granulocyte–macrophage colony-forming units (CFU-GM). Exposure to MA also decreased interleukin-2 production by splenocytes. In contrast, splenic NK activity in exposed mice was significantly enhanced. Taken together, data indicate that the immune system was suppressed by oral MA exposure.

1 March 2003 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
SMSung -Ji Mo
Sung -Ji Mo
ESEun -Wha Son
Eun -Wha Son
DRDong -Kwon Rhee
Dong -Kwon Rhee
SPSuhkneung Pyo
Suhkneung Pyo

1 June 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
HLHee-Weon Lee
Hee-Weon Lee
DRDong-Kwon Rhee
Dong-Kwon Rhee
BKByung-Oh Kim
Byung-Oh Kim
SPSuhkneung Pyo
Suhkneung Pyo